Prostate cancer Board decisions

The Board has remanded the issue of service connection for a bilateral foot condition due to new evidence and development. The Veteran's COPD and prostate cancer are denied as not shown to be causally related to his military service.

The Board denied an earlier effective date for TDIU due to prostate cancer residuals, finding that there was no pending claim and the Veteran did not have a valid claim before September 8, 2010.

The Board denied the Veteran's claim for service connection for prostate cancer, finding no evidence of a relationship to his military service or herbicide exposure.

The Board denied the Veteran's claims for service connection due to lack of new and material evidence, as no evidence was received that could substantiate his exposure to radiation in service or link his current conditions to service.

The Board has remanded the issues of earlier effective dates for prostate cancer service connection, rating from June 27, 2016 to October 18, 2018, and TDIU prior to November 21, 2016.

The Veteran's petition to reopen the claim for hypertension was denied as new and material evidence was not submitted.,A rating of 60 percent for service-connected residuals of prostate cancer from October 19, 2015 to July 18, 2016 was granted.

The Board has remanded the claims for service connection for bladder cancer, gall bladder cancer, and prostate cancer due to exposure to ionizing radiation. The Under Secretary for Health will prepare a dose estimate based on the Veteran's reported proximity to contaminated ships during his guard duty at Mare Island Naval Shipyard and his three days of firefighter training at Treasure Island in April 1947.

The Board has granted service connection for left ear hearing loss. Right ear hearing loss, prostate cancer, and type II diabetes mellitus are remanded due to the need for additional development.

The appeal for service connection of lung cancer and prostate cancer is dismissed due to the Veteran's death.

The Board has remanded the Veteran's claim for service connection for a prostate disability, including prostate cancer, due to insufficient medical opinion and new evidence.

The Board denied service connection for prostate cancer and SMC based on loss of use of a creative organ as the evidence did not support a finding that the Veteran's conditions were related to his military service.

The Veteran's claim for an initial rating in excess of 60 percent for residuals of prostate cancer was denied. The Board also found that the Veteran's bilateral ischemic optic neuropathy is not related to service, and thus denied his claim for service connection.

The Veteran's prostate cancer is granted as service connected due to exposure to Agent Orange during his service in Thailand.

Service connection is granted for prostate cancer due to herbicide exposure. The case is remanded for further examination and opinion regarding radiation proctitis and depressive disorder.

The Board has remanded the case due to incomplete records and lack of verification for exposure to Agent Orange. The Veteran's prostate cancer is being reviewed again with additional information provided.

The Veteran's appeal for TDIU was withdrawn, and the Board dismissed it. The Veteran is granted special monthly compensation based on his need for aid and attendance due to service-connected disabilities.

The Board has decided to remand the cases for further action due to issues with the reduction of the Veteran's disability rating and the need for an updated examination.

The Board has remanded the claims of service connection for prostate cancer and entitlement to TDIU due to insufficient information regarding the Veteran's exposure to herbicides while stationed at Ubon Airfield, Thailand.

The Veteran's prostate cancer was found to have manifested by the time of his May 29, 2013 claim for service connection. An effective date of May 29, 2013 is granted.

The Veteran's prostate cancer and coronary artery disease were not rated higher than the assigned levels from May 5, 2011 through December 31, 2015.